Cairn Investment Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
17,800
+2,500
| +16% | +$196K | 0.73% | 37 |
|
|
2025
Q1 | $1.11M | Sell |
15,300
-900
| -6% | -$65.2K | 0.63% | 38 |
|
|
2024
Q4 | $1.2M | Hold |
16,200
| – | – | 0.7% | 39 |
|
|
2024
Q3 | $1.07M | Hold |
16,200
| – | – | 0.59% | 42 |
|
|
2024
Q2 | $1.5M | Hold |
16,200
| – | – | 0.87% | 35 |
|
|
2024
Q1 | $1.55M | Hold |
16,200
| – | – | 0.89% | 36 |
|
|
2023
Q4 | $1.24M | Hold |
16,200
| – | – | 0.77% | 38 |
|
|
2023
Q3 | $1.12M | Hold |
16,200
| – | – | 0.74% | 38 |
|
|
2023
Q2 | $1.53M | Hold |
16,200
| – | – | 0.99% | 29 |
|
|
2023
Q1 | $1.34M | Sell |
16,200
-335
| -2% | -$27.7K | 0.93% | 33 |
|
|
2022
Q4 | $1.23M | Buy |
16,535
+335
| +2% | +$25K | 0.92% | 37 |
|
|
2022
Q3 | $1.34M | Sell |
16,200
-1,400
| -8% | -$116K | 1.08% | 30 |
|
|
2022
Q2 | $1.67M | Hold |
17,600
| – | – | 1.3% | 29 |
|
|
2022
Q1 | $2.85M | Hold |
17,600
| – | – | 1.81% | 20 |
|
|
2021
Q4 | $2.28M | Hold |
17,600
| – | – | 1.57% | 22 |
|
|
2021
Q3 | $1.99M | Hold |
17,600
| – | – | 1.47% | 24 |
|
|
2021
Q2 | $1.82M | Sell |
17,600
-100
| -0.6% | -$10.4K | 1.34% | 26 |
|
|
2021
Q1 | $1.48M | Hold |
17,700
| – | – | 1.23% | 31 |
|
|
2020
Q4 | $1.62M | Hold |
17,700
| – | – | 1.53% | 26 |
|
|
2020
Q3 | $1.41M | Hold |
17,700
| – | – | 1.5% | 26 |
|
|
2020
Q2 | $1.22M | Sell |
17,700
-1,200
| -6% | -$82.9K | 1.49% | 31 |
|
|
2020
Q1 | $1.19M | Hold |
18,900
| – | – | 1.77% | 24 |
|
|
2019
Q4 | $1.47M | Buy |
+18,900
| New | +$1.47M | 1.46% | 31 |
|